This study investigates the green synthesis of silver nanoparticles (AgNPs) using Cardiospermum halicacabum leaf extract, which acts as both a reducing and stabilizing agent. The biosynthesis approach is eco-friendly and leverages the phytochemical constituents of Cardiospermum halicacabum. Characterization of the synthesized AgNPs was performed using scanning electron microscopy (SEM), X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR), confirming the formation of nanoparticles with desired properties. SEM analysis revealed the morphology and size distribution of the AgNPs, while XRD provided insights into their crystalline nature, and FTIR identified functional groups involved in the reduction and stabilization processes. Despite the successful synthesis of AgNPs, antimicrobial assays indicated that these nanoparticles did not exhibit significant antibacterial activity against tested microorganisms such as Escherichia coli and Staphylococcus aureus. The results suggest that the synthesized AgNPs require further optimization to enhance their antimicrobial efficacy. This study underscores the potential of Cardiospermum halicacabum in green nanoparticle synthesis and highlights the need for continued research to understand the factors influencing the antimicrobial properties of biosynthesized AgNPs, aiming to improve their effectiveness for clinical and industrial applications.
No takes yet. Share an insight, caveat, or question.
Inbanathan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: